Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chropaxe
- Development stage
- Unknown
- Lead developer
- Charak
- Administration
- Oral
01
Overview
Chropaxe is an Ayurvedic proprietary herbal formulation developed by Charak for the management of chronic pain and discomfort. It is formulated as an oral tablet containing a synergistic blend of traditional herbs, including Ashwagandha (*Withania somnifera*), Gokshur (*Tribulus terrestris*), Tagar (*Valeriana wallichii*), Shunthi (*Zingiber officinale*), and Shyonak (*Oroxylum indicum*). Chropaxe is indicated for chronic pain conditions such as chronic neck pain, low back pain, headache, migraine, sciatica, and psychosomatic pain. It is designed to alleviate pain and inflammation, increase the pain threshold, and improve joint mobility without the risk of addiction associated with conventional prescription pain medications.
- Brand names
- Chropaxe
- Other names
- Chropaxe TabletChropaxe Tablets
Beyond the preview
Go deeper on Chropaxe.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chropaxe.